Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer

Fig. 2

Kaplan–Meier survival curves according to the ESCC-PS in validation cohort. A Kaplan–Meier survival curves of PFS (2.7 vs 4.8 vs 16.7 months, P < 0.001) according to the ESCC-PS. B. Kaplan–Meier survival curves of OS (6.3 vs 20.2 months vs Unreached, P < 0.001) according to the ESCC-PS. PFS progression-free survival, OS overall survival, ESCC-PS esophageal squamous cell cancer-pathomics signature

Back to article page